Related Experiment Video
Updated: Feb 10, 2026
04:11
Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
Published on: April 28, 2023
2.6K
[TREATMENT OPTIONS FOR DIABETIC MACULAR EDEMA]
Efraim Berco1, Daniel Rappoport1,2, Ayala Pollack1,2
1Ophthalmology Department, Kaplan Medical Center, Rehovot.
Harefuah
|May 29, 2017
Summary
Anti-vascular endothelial growth factor (VEGF) therapy and intravitreal steroids are emerging treatments for diabetic macular edema (DME), a leading cause of vision loss. These therapies offer improved outcomes compared to traditional laser photocoagulation for diabetic retinopathy patients.
Area of Science:
- Ophthalmology
- Endocrinology
- Medical Retina
Background:
- Diabetic retinopathy (DR) is a primary cause of vision loss in adults under 65.
- Diabetic macular edema (DME), a complication of DR, frequently causes moderate visual impairment.
- Traditional laser photocoagulation for DME stabilizes vision but offers limited visual acuity improvement.
Purpose of the Study:
- To review emerging treatment options for diabetic macular edema (DME).
- To compare the efficacy of novel therapies against established treatments for DME.
Main Methods:
- Review of recent clinical studies and therapeutic advancements in DME management.
- Analysis of data on anti-vascular endothelial growth factor (anti-VEGF) agents and intravitreal steroids.
Main Results:
- Anti-VEGF therapy demonstrates significant resolution of DME and visual acuity gain.
- Intravitreal steroids are effective, particularly for refractory DME cases, due to anti-inflammatory properties.
Conclusions:
- Anti-VEGF therapy is now the first-line treatment for DME.
- Intravitreal steroids offer a valuable alternative for specific DME patient populations.
- Emerging treatments represent a significant advancement in managing DME and preserving vision.
Related Concept Videos
01:20Pathophysiology of Diabetes
3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:19Psychoneuroimmunology: Diabetes and Cancer
506
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K
01:22Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K